コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 raction [PDFF] and subcutaneous and visceral abdominal fat).
2 dback response by NPY leads to the growth of abdominal fat.
3 in a glucocorticoid-dependent manner in the abdominal fat.
4 ght gain can be assumed to be fat, including abdominal fat.
5 ng glucose, glycated hemoglobin, or visceral abdominal fat.
6 eous fat area (r = 0.760) but not with intra-abdominal fat.
7 Exercise training also reduces total and abdominal fat.
8 rweight, nor the detrimental effect of intra-abdominal fat.
9 ree fatty acid kinetics, and increased intra-abdominal fat.
10 retion of insulin, and 3) increases in intra-abdominal fat.
11 ntal in the accumulation of intrahepatic and abdominal fat.
12 djustment, whereas the opposite was seen for abdominal fat.
13 in a glucocorticoid-dependent manner in the abdominal fat.
14 Participants lost 2.3 +/- 0.2 kg (13.8%) abdominal fat: 1.5 +/- 0.2 kg (13.6%) subcutaneous fat a
15 [pmol/l]), P < 0.01) was decreased and intra-abdominal fat (117 +/- 10 vs. 81 +/- 9 cm(2), P < 0.05)
16 t (13.4%), subcutaneous (19.9%) and visceral abdominal fat (25.8%), trunk fat (18%), and lean mass (1
17 5% CI, -17.8 to 0.9 g/cm2), and subcutaneous abdominal fat (-28.8 g/cm2); 95% CI, -47.5 to -10.0 g/cm
19 y fat (-1.0%; 95% CI, -1.6% to -0.4%), intra-abdominal fat (-8.6 g/cm2; 95% CI, -17.8 to 0.9 g/cm2),
21 mia (Cushing's syndrome) is characterised by abdominal fat accumulation and gluteofemoral fat loss.
23 iral-treated HIV-infected men and women with abdominal fat accumulation at Massachusetts General Hosp
24 ar diseases; recent findings have shown that abdominal fat accumulation can be an independent predict
26 d studies, men and women with HIV-associated abdominal fat accumulation were randomly assigned (ratio
27 bo-controlled trial of 56 patients with HIV, abdominal fat accumulation, and reduced GH secretion (pe
28 t the diabetic rats develop liver steatosis, abdominal fat accumulation, nephropathy, atrophy of panc
29 liminary study of HIV-infected patients with abdominal fat accumulation, tesamorelin administered for
31 from veins draining subcutaneous femoral and abdominal fat and compared with arterialized blood sampl
33 y contribute to the abnormal distribution of abdominal fat and hepatic steatosis, as well as to insul
34 robic exercise intensity affects the loss of abdominal fat and improvement in cardiovascular disease
35 d similar leptin levels, whereas their intra-abdominal fat and insulin sensitivity remained different
36 h AE and RE alone are effective for reducing abdominal fat and intrahepatic lipid in obese adolescent
37 od for quantifying subcutaneous and visceral abdominal fat and its distribution in preadolescents and
41 s of predominately white ethnicity had intra-abdominal fat and subcutaneous fat areas measured as par
42 nventional anthropometric indices with intra-abdominal fat and subcutaneous fat areas measured by mag
47 n of symptoms was associated with changes in abdominal fat and whether such changes were associated w
49 icantly reduced body-weight gain, diminished abdominal fat, and increased nonalcoholic steatohepatiti
52 e association between birth weight and adult abdominal fat appeared to be specific to visceral fat.
54 atios of hypertension for quartiles of intra-abdominal fat area (1 = lowest; 4 = highest) were 5.07 (
62 mass index is used as a surrogate for intra-abdominal fat area in men, a quadratic term should be in
75 ed positively with visceral and subcutaneous abdominal fat areas and negatively with lower-body fat m
77 t body fat, intra-abdominal and subcutaneous abdominal fat areas, resting metabolic rate, substrate o
78 rmance of immunoelectron microscopy (IEM) of abdominal fat aspirates from 745 consecutive patients wi
87 e association between birth weight and total abdominal fat [B (partial regression coefficient express
90 t known as a yolk protein synthesized in the abdominal fat body, acts as an antioxidant to promote lo
92 ows lower metabolic fluxes than subcutaneous abdominal fat, but differs in its relative preference fo
98 rization techniques to examine whether intra-abdominal fat contributes a greater portion of hepatic F
100 easures of total, subcutaneous, and visceral abdominal fat decreased with training, whereas total bod
101 C-reactive protein (beta=-0.20, P<0.002) and abdominal fat deposit (beta=-0.20, P<0.003); for tissue
102 eta=-0.43, P<0.0001); for tissue E velocity, abdominal fat deposit (beta=-0.30, P<0.0001), PICP (beta
103 e S velocity, PICP (beta=-0.21, P<0.002) and abdominal fat deposit (beta=-0.43, P<0.0001); for tissue
104 independently associated with the extent of abdominal fat deposit, profibrotic state (as reflected b
105 to associate with more adverse change in the abdominal fat deposition in the high-fat diet group than
107 sults indicate that among men, greater intra-abdominal fat deposition rates occur at relatively low b
108 opsy samples were obtained from subcutaneous abdominal fat depots, and preadipocytes were isolated an
109 bsorptiometry (DXA) can be used to determine abdominal fat depots, being more accessible and less cos
112 MI and dual-energy X-ray absorptiometry) and abdominal fat distribution (measured by magnetic resonan
114 nuclear magnetic resonance spectroscopy and abdominal fat distribution by magnetic resonance imaging
116 f NPY variant rs16147 on central obesity and abdominal fat distribution in response to dietary interv
117 ts of diet-induced weight loss on changes in abdominal fat distribution in white and black women.
119 cleotide polymorphism on central obesity and abdominal fat distribution were modified by dietary fat.
125 f other GWAS risk SNPs were tissue-specific; abdominal fat emerged as an important gene-regulatory si
126 (n=7) had a greater loss in body-mass index, abdominal fat, fat tissue, and lean tissue, compared wit
127 her measures included subcutaneous and intra-abdominal fat from computed tomography scans, weight, an
128 component of central adiposity, subcutaneous abdominal fat has as strong an association with insulin
131 the insulin sensitivity index (Si) and intra-abdominal fat (IAF) and subcutaneous fat (SCF) areas.
134 mined the accuracy of DXA for measurement of abdominal fat in an Indian population by comparison with
136 h weight and adult visceral and subcutaneous abdominal fat in the population-based Fenland study.
139 with high meal frequency increased IHTG and abdominal fat independent of caloric content and body we
142 This study was undertaken to investigate how abdominal fat is distributed in rheumatoid arthritis (RA
146 udies have evaluated the association between abdominal fat mass (AFM) and bone health beyond its weig
147 only slightly overestimated MRI measures of abdominal fat mass (mean difference in L1L4 region: 2% (
148 epilepsy (TLE), exhibited gross expansion of abdominal fat mass and significant weight gain several m
150 easurement of hepatic fat fraction (HFF) and abdominal fat mass distribution, along with lipid profil
152 ecreased ovarian reserve and increased intra-abdominal fat mass in granddaughters, accompanied by acc
154 was associated with a tendency for a higher abdominal fat mass percentage (quartile 4 compared with
155 ly greater percent body fat and subcutaneous abdominal fat mass than did the never-obese women, and t
157 interscapular brown adipose tissue and intra-abdominal fat mass, and increased extra-abdominal subcut
158 ist circumference, as estimates of total and abdominal fat mass, are now accepted as predictors of th
159 fore pregnancy because it is unknown whether abdominal fat mass, independently of body size, affects
164 tion by DXA greater in individuals with less abdominal fat (mean bias in leaner half of sample was 6%
165 6-month change in visceral and subcutaneous abdominal fat measured by magnetic resonance imaging and
166 95% CI: 17%, 29%) highly correlated with DXA abdominal fat measurements (mean, 26%; 95% CI: 21%, 31%)
168 associated with higher childhood general and abdominal fat measures (P-trend < 0.05) but not with hig
169 examined the associations of total body and abdominal fat measures with respiratory resistance (Rint
171 unique phenotype were highly enriched in the abdominal fat of normal mice, but their numbers were str
172 on with age is related to increases in intra-abdominal fat or age per se, we studied 220 healthy subj
174 differences in changes in body composition, abdominal fat, or hepatic fat between assigned macronutr
175 introduction of solid foods with general and abdominal fat outcomes are explained by sociodemographic
179 dipose lipid) was greater in gluteal than in abdominal fat (P = 0.022) in LOb women, but not in UOb w
181 as inversely associated in men with visceral abdominal fat (P for trend = 0.02) and not significantly
186 c syndrome, is the close interaction between abdominal fat patterning, total body adiposity, and insu
188 tudy explored the degree to which changes in abdominal fat quantity and quality are associated with c
189 age was associated with S(i), but both intra-abdominal fat (r = -0.198, P = 0.003) and age (r = -0.13
191 .58), visceral fat (r = -0.52), subcutaneous abdominal fat (r = -0.61), and thigh fat (r = -0.38) and
193 ther altered partitioning of myocellular and abdominal fat relates to abnormalities in glucose homoeo
194 n stepwise multiple regression, subcutaneous abdominal fat retained significance after adjusting for
195 and a proportional reduction in subcutaneous abdominal fat (SAT); the VAT-SAT ratio was unchanged in
197 h insulin resistance or whether subcutaneous abdominal fat shares this link has generated controversy
198 en with higher baseline percentage trunk and abdominal fat showed increases in LOC eating episode fre
199 on energy storage by surgically ablating the abdominal fat stores from half of the females in each re
201 of liposomes (Kliposome/water), (iii) human abdominal fat tissues (KAFT/water) from seven individual
202 that the THRSPalpha locus is associated with abdominal fat traits in a broilerxLeghorn resource popul
203 magnetic resonance spectroscopy ((1) H-MRS), abdominal fat using magnetic resonance imaging (MRI), an
204 c function, and computed tomography visceral abdominal fat (VAF) measurements at baseline and 6 month
205 intrathoracic fat, pericardial fat, visceral abdominal fat (VAT), coronary artery calcification, and
206 y was associated with a decrease in visceral abdominal fat (VAT; -1115 [819] vs 1191 [699] mm(2); P =
209 xperiences of discrimination and subtypes of abdominal fat (visceral, subcutaneous) in a population-b
221 dy fat, percentage trunk fat, and percentage abdominal fat were related to greater body dissatisfacti
223 a greater percentage trunk fat, specifically abdominal fat, were at highest risk of developing LOC ea
224 -) female mice having a higher proportion of abdominal fat when compared with wild-type female mice.
225 ved, but there is not a preferential loss of abdominal fat when either moderate- or vigorous-intensit
226 hs of age displayed aberrant accumulation of abdominal fat when maintained on standard rodent chow, w
227 0.02) were associated with the percentage of abdominal fat, whereas SFA (b = 0.27; P = 0.04) and PUFA
228 que that allows rapid noninvasive imaging of abdominal fat without the potentially harmful effects of
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。